CATALOGO DEI PRODOTTI DELLA RICERCA

BELLINATO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.295
NA - Nord America 1.133
AS - Asia 749
AF - Africa 64
OC - Oceania 43
SA - Sud America 42
Totale 3.326
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.102
IT - Italia 308
SG - Singapore 293
CN - Cina 262
RU - Federazione Russa 235
IE - Irlanda 159
SE - Svezia 132
FR - Francia 98
DE - Germania 94
GB - Regno Unito 82
FI - Finlandia 55
ID - Indonesia 51
TG - Togo 47
AU - Australia 39
BR - Brasile 29
NL - Olanda 27
TR - Turchia 26
ES - Italia 24
HK - Hong Kong 18
IN - India 16
CA - Canada 15
JP - Giappone 15
IR - Iran 14
MX - Messico 14
MY - Malesia 11
SA - Arabia Saudita 10
UA - Ucraina 10
CL - Cile 9
KR - Corea 9
PL - Polonia 9
DK - Danimarca 8
PH - Filippine 8
BE - Belgio 7
AT - Austria 6
CH - Svizzera 6
HR - Croazia 6
IS - Islanda 5
RO - Romania 5
DZ - Algeria 4
EG - Egitto 4
IL - Israele 4
NZ - Nuova Zelanda 4
ET - Etiopia 3
NO - Norvegia 3
PT - Portogallo 3
CO - Colombia 2
CZ - Repubblica Ceca 2
JO - Giordania 2
LT - Lituania 2
MA - Marocco 2
NG - Nigeria 2
PK - Pakistan 2
TW - Taiwan 2
AD - Andorra 1
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
EC - Ecuador 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GT - Guatemala 1
KE - Kenya 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
NP - Nepal 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 3.326
Salva come PNG Salva come JPEG
Città #
Chandler 267
Singapore 243
Dublin 148
Ashburn 142
Beijing 59
Jakarta 48
Lomé 47
Helsinki 41
New York 40
Southend 39
Lawrence 34
Princeton 34
Milan 30
Sindelfingen 25
Wilmington 25
Houston 24
Jacksonville 24
Seattle 24
Washington 24
Verona 22
Munich 19
Rome 17
Sydney 16
Venice 16
Dallas 15
Moscow 15
Amsterdam 14
Lappeenranta 14
Hong Kong 13
Santa Clara 13
Enfield 12
Frankfurt am Main 12
Bologna 11
Guangzhou 11
Kuala Lumpur 11
London 11
Los Angeles 11
Naples 11
Chicago 9
Dongguan 9
Esslingen am Neckar 9
Perth 9
Turin 9
Jinan 8
Madrid 8
Mersin 8
Shanghai 8
Tokyo 8
Copenhagen 7
Council Bluffs 7
Phoenix 7
San Jose 7
Ann Arbor 6
Atlanta 6
Brussels 6
Genoa 6
Kent 6
Mexico City 6
Mumbai 6
Pescara 6
Redwood City 6
Riyadh 6
Santiago 6
Seoul 6
Warsaw 6
Chennai 5
Hebei 5
Nanjing 5
Pasig 5
Redmond 5
Tianjin 5
Toronto 5
Adelaide 4
Albano Laziale 4
Brisbane 4
Bucharest 4
Constantine 4
Florence 4
Fuzhou 4
Giresun 4
Las Vegas 4
Nova Iguaçu 4
Palermo 4
Ta'if 4
Vicenza 4
Woodbridge 4
Xi'an 4
Zagreb 4
Zhengzhou 4
Zurich 4
Addis Ababa 3
Barcelona 3
Bari 3
Berlin 3
Besana in Brianza 3
Campbelltown 3
Fairfield 3
Faskrudsfjoerdur 3
Hangzhou 3
Lund 3
Totale 1.910
Salva come PNG Salva come JPEG
Nome #
Dietary supplements for lipedema 212
Il ruolo della vitamina D nella dermatite atopica 159
Polymorphisms, diet and nutrigenomics 107
A systematic review of treatments for pityriasis lichenoides 90
Impact of the COVID-19 pandemic on melanoma diagnosis 80
BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis. 72
Amicrobial Pustulosis of the Folds: Report of Three New Cases 65
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 65
A dermatologist perspective in the pharmacological treatment of patients with psoriasis and psoriatic arthritis 62
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 60
Alopecic and aseptic nodules of the scalp: A new case with a systematic review of the literature 60
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 60
Hypochondriasis and Personality Traits of Patients with Chronic Plaque Psoriasis 55
Coexistence of scleromyxedema and Sneddon syndrome 54
Persistent localized hypertrichosis in a Caucasian child at sites of DTPa and chickenpox vaccination 53
Consensus on the place in therapy of TNF-a inhibitors in the treatment of patients with chronic plaque psoriasis 51
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 51
Clinical‐epidemiological aspects of the Monkeypox 2022 epidemic: a multicenter study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases 50
Adrenergic urticaria successfully treated with omalizumab 50
Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis 50
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis 50
Dietary supplements for the management of COVID-19 symptoms 48
Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review 47
Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease 47
The transition from mild to moderate-to-severe chronic plaque psoriasis 46
Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities 46
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines 46
Clinical profile and co-infections of urethritis in males 43
Dermoscopic features of nevoid melanoma: a retrospective study 42
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study 42
Relapse of psoriasis in patients who asked to discontinue etanercept after achieving a stable clinical remission. 42
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series 41
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 40
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis 40
IL-17A inhibitors in patients with chronic plaque psoriasis and history of malignancy: A case series with systematic literature review 40
Comparative dermoscopy assessment of nevus-associated versus de novo in situ melanoma 39
Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules 39
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis 38
The safety profile of hydroxychloroquine: major cutaneous and extracutaneous adverse events 38
Methotrexate vs secukinumab safety in psoriasis patients with metabolic syndrome 38
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 37
In vitro cell culture of amniotic fluid keratinocytes on amniotic membrane: the ideal tissue for repairing skin ulcers 36
Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies 35
Skin adverse reactions to Sars‐CoV‐2 vaccination: a relevant responsibility issue for dermatologists 35
Primary nodular localized cutaneous amyloidosis of the scalp associated with systemic lupus erythematosus 35
Predictors of subsequent primary melanoma: a case-control study 34
The Risk of COVID‐19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments 34
Main nutritional deficiencies 33
Monkeypox virus infection: what dermatologist needs to know? 31
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 30
Risk of lymphohematologic malignancies in patients with chronic plaque psoriasis: A systematic review with meta-analysis 30
Price variability of TNF-α inhibitor biosimilars among European countries 30
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis 29
Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies 29
Could Targeted Pharmacotherapies Exert a "Disease Modification Effect" in Patients with Chronic Plaque Psoriasis? 29
Dupilumab for recalcitrant Kimura disease 28
The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV2 infection and vaccination 26
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis 26
Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs 25
Scurvy as Presenting Sign of Anorexia Nervosa 25
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis 24
Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis 24
Use of biologics during the COVID-19 pandemic: lessons learned from psoriasis 24
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment 24
Is risankizumab as needed administration a good option for patients with plaque psoriasis? 23
Topographic Differential Diagnosis of Chronic Plaque Psoriasis: Challenges and Tricks 22
Optimization of long-range PCR protocol to prepare filaggrin exon 3 libraries for PacBio long-read sequencing 21
Managing the Patient with Psoriasis and Metabolic Comorbidities 20
Pretibial Dystrophic Epidermolysis Bullosa Successfully Treated with Upadacitinib: A Case Report 20
Polyphenols and Lactobacillus reuteri in oral health 19
Validating methods for testing natural molecules on molecular pathways of interest in silico and in vitro 19
Corymbose Syphilis 17
Systematic study on nail plate assessment: differences in nail plate shape, thickness, power Doppler signal and scanning approach 16
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohort 14
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis 14
Awareness of obesity among patients with psoriasis 14
Psoriasis: talking points from recent clinical trials 14
Generalized pustular psoriasis successfully treated with spesolimab: A case report 13
Long-term follow-up of Zoon balanitis: a retrospective cohort study 12
Lamivudine, Doravirine, and Cabotegravir downregulate the expression of Human Endogenous Retroviruses (HERVs), inhibit cell growth, and reduce invasive capability in melanoma cell lines 12
The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments 11
Omics sciences and precision medicine in melanoma 11
X-linked genodermatoses from diagnosis to tailored therapy 11
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 11
Novel loss-of-function variants in filaggrin exon 3 in patients with severe atopic dermatitis 10
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study 9
Diagnosis and Treatment of Infantile Hemangioma from the Primary Care Paediatricians to the Specialist: A Narrative Review 7
PsoBioVax: A multicentric Italian case–control study of the immunological response to anti‐SARS‐CoV‐2 vaccine among psoriatic patients under biological therapy 6
BRAF-Mutated Melanoma Cell Lines Develop Distinct Molecular Signatures After Prolonged Exposure to AZ628 or Dabrafenib: Potential Benefits of the Antiretroviral Treatments Cabotegravir or Doravirine on BRAF-Inhibitor-Resistant Cells 3
Totale 3.420
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.788
article - articoli 18.788
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.576
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 0 0 0 1 3 12 3 6
2020/202195 9 6 1 14 15 14 10 1 4 4 13 4
2021/2022224 12 27 4 12 31 12 15 16 11 12 17 55
2022/20231.126 38 72 63 144 63 203 15 53 210 157 78 30
2023/2024940 59 64 97 102 82 166 67 57 16 44 108 78
2024/2025994 119 104 125 379 118 145 4 0 0 0 0 0
Totale 3.420